This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm CI
EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023 CI
Medtronic Korea Holdings Co., Ltd. cancelled the acquisition of 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim. CI
US-based Medtronic Acquires EOFlow MT
Eoflow to Raise 314.9 Billion Won via Shares Issuance MT
Medtronic Korea Holdings Co., Ltd. agreed to acquire a 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim for approximately KRW 170 billion. CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 314.903773785 billion in funding from Medtronic Korea Holdings Co., Ltd. CI
Pharmeo Inc. announced that it has received KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd. CI
Pharmeo Inc. announced that it expects to receive KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd. CI
EOFLOW Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd. CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd. CI
Pharmeo Inc. announced that it has received KRW 9.9078 billion in funding from EOFLOW Co.,Ltd. CI
Pharmeo Inc. announced that it expects to receive KRW 9.9078 billion in funding from EOFLOW Co.,Ltd. CI
Diabeloop and EOFLOW Co.,Ltd. Partners to Offer Wearable Aid with Smartphone App CI
EOFlow Co., Ltd. Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch' CI
EOFLOW Co.,Ltd. and Zihipp Limited Announce Joint Venture for Development of Innovative Solutions for Treatment of Obesity & Nash CI
EOFLOW Co.,Ltd. announced that it has received KRW 9.2170284 billion in funding from Sinocare Inc. CI
Biolinq Inc announced that it has received $100 million in funding from a group of investors CI
Eoflow to Raise $120 Million From Share Sale MT
Eoflow to Raise Nearly $8 Million Through Stock Offering MT
EOFLOW Co.,Ltd. announced that it expects to receive KRW 9.2170284 billion in funding from Sinocare Inc. CI
Biolinq Inc announced that it expects to receive funding CI
EOFLOW Co.,Ltd. announced that it has received KRW 3.50004641 billion in funding from UXN Co., Ltd. CI
UXN Co., Ltd. announced that it has received KRW 5.00024544 billion in funding from EOFLOW Co.,Ltd. and other investors CI
Chart EOFLOW Co.,Ltd.
More charts
EOFlow Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company's main products include wearable insulin pumps, insulin infusion regulators for blood sugar control in diabetic patients.
More about the company
  1. Stock Market
  2. Equities
  3. A294090 Stock
  4. News EOFLOW Co.,Ltd.
  5. Eoflow to Raise Nearly $8 Million Through Stock Offering